Jun 01, 2020
Natera Launches Quantification Technique to Enhance Prospera(TM) Test Precision; Initiates PEDAL Study for New Insights
May 26, 2020
Natera Announces New Prospera(TM) Data at ATC Showcasing Innovation in Cell-Free DNA
May 19, 2020
Natera Announces New Data at ASCO Highlighting Utility of Personalized MRD Monitoring
May 11, 2020
Prospera(TM) Receives Positive Medicare Coverage
Apr 15, 2020
Natera Asserts Three New Oncology Patents Against ArcherDX
Apr 14, 2020
Natera Prices $250 Million Convertible Senior Notes Due 2027
Apr 13, 2020
Natera to Offer $250 Million Convertible Senior Notes Due 2027
Apr 02, 2020
New Study Shows Benefit of Using Signatera(TM) Technology for Personalized Monitoring in Gastrointestinal Cancer
Feb 26, 2020
Natera Reports Fourth Quarter and Year 2019 Financial Results
Feb 18, 2020
Natera Files False Advertising Counterclaim Against CareDx
Feb 17, 2020
Women Opting for Late Motherhood Driving Demand for Non-invasive Prenatal Testing: Transparency Market Research
Feb 14, 2020
Global Non-Invasive Prenatal Testing (NIPT) Industry Forecasts, 2020 to 2027 - Untapped Emerging Markets Present Lucrative Opportunities
Jan 27, 2020
Natera Files Suit Against ArcherDX for Patent Infringement
Jan 09, 2020
Natera Launches BESPOKE CRC Study to Evaluate Outcomes in 1,000 Signatera(TM) Patients with Stage II-III Colorectal Cancer
Jan 06, 2020
Natera Announces Achievement of $55 Million In Pharma Contracts and Issuance of New Oncology Patents
Dec 19, 2019
Global Non-Invasive Prenatal Testing Markets, 2018-2019 & 2027F - World Market Set to be Valued at $6.4 Billion by 2027
Dec 19, 2019
Natera Receives Final Medicare Coverage for Prospera(TM) Organ Transplant Rejection Assessment Test
Nov 12, 2019
United States Non-Invasive Prenatal Testing Market to 2027 Featuring Major Players - Natera, Illumina, Laboratory Corporation of America Holdings
Nov 06, 2019
Natera Reports Third Quarter 2019 Financial Results
Oct 16, 2019
Natera Announces Pricing of Follow-On Offering